Jim Cramer Recommends Two Stocks Sees Nearly 20 Upside in One Microsoft Taps Accessibility Veteran to Steer Trustworthy AI Development Amid Speed vs Responsibility Debate Strategy Pauses Bitcoin Accumulation to Prioritize 15B Bond Repurchase Nifty Faces Resistance as Financial IT Sectors Weigh Market Outlook for Friday Lowes Stock May Be Underestimated Says Jim Cramer Nvidia Posts Record Earnings But Shares Dip as Growth Concerns Mount Equinor Q1 2026 Earnings Strong EPS Beat Amid Operational Efficiency Haverty Furniture Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher TTD Q1 2026 Earnings EPS Misses Estimates Stock Declines Prestige Consumer Healthcare Inc Q1 2026 Earnings EPS Miss Overshadows Steady Operations Evommune Inc EVMN Q1 2026 Earnings EPS Beats Estimates as PreRevenue Biotech Focuses on Pipeline Progress Allient Inc ALNT Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Edges Higher First Internet Bancorp INBK Retreats Slightly as Stock Tests Nearby Support Levels Euroseas Ltd ESEA Sees Mild Decline as Shares Approach Key Support Near 61 Compania Cervecerias Unidas CCU Rallies 216 as Shares Test Resistance Near 1264 KALA Bio Dips 65 Support Test Looms as Biotech Faces Pressure Aprea Therapeutics APRE Edges Higher Amid Light Trading Key Resistance at 099 in Focus SpaceX IPO Plans Blockbuster Spending on Rockets and AI Signals Potential RecordBreaking Listing APA Corporation APA Q1 2026 Earnings EPS Surges Past Estimates But Stock Declines Amidst Mixed Signals UroGen Pharma URGN Advances 197 Approaching Key Resistance at 3093